Clinical Trial Update: Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on raltegravir in patients with end-stage liver disease and in liver transplant recipients, reporting safety and pharmacokinetic consider…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Liver Failure
• Liver Transplantation

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV Infection, Liver Failure | Phase 1, Phase 2 | Status: COMPLETED